EpiVario is a pharmaceutical company that develops treatments for memory-related psychiatric disorders. It focuses on patients suffering from post-traumatic stress disorder, alcohol and drug addiction, Alzheimer’s disease, and dementia. The company offers a small molecule inhibitor of ACSS2 to modulate an epigenetic process that controls neuronal plasticity.